DLDaniel J. Lee

Daniel J. Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel J. Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy

    by Daniel J. Lee, Chad Ritch, Manisha Desai, Mitchell C. Benson, James M. McKiernan

    Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVE: • To examine the interaction of body mass index (BMI) and race in predicting biochemical failure (BCF) after radical prostatectomy (RP). The relative contribution of BMI and race to BCF after RP has not been well characterized. PATIENTS AND METHODS: • From 1988 to 2008, 969 white and black men underwent RP and BMI data were available. In all, 168 (17.3%) were black and 801 (82.7%) were white men. • BCF was defined as a post‐surgery PSA level ≥0.2 ng/mL on ≥2 measurements. Cox regression methods were used to model the relationship between race, BMI and BCF. RESULTS: • The 969 men had a mean age of 59.8 ± 7.2 years. There was no significant difference in BMI between black and white men ( P = 0.32). • The 5‐year disease‐free survival for black obese men was the lowest at 48%, compared with non‐obese black (73%), obese white (82%) and non‐obese white men (83%, P < 0.001). • BMI did not have a significant impact on BCF. In a multivariate analysis, black race remained an independent predictor of BCF [hazard ratio (HR) = 1.76, P = 0.01]. • BMI does not affect the risk of BCF in black men differently than white men ( P value for interaction 0.93). CONCLUSIONS: • Black race is an independent predictor of biochemical failure after adjusting for pathological factors. The impact of BMI on BCF did not vary among different races. • These findings suggest that elevated BMI does not affect the BCF rates of black men more than in other races, and that other factors may influence the racial variability in disease‐free survival and BCF risk.


  • Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys

    by Daniel J. Lee, Greg Hruby, Mitchell C. Benson, James M. McKiernan

    Introduction With low life expectancy rates in hemodialysis patients, the preservation of renal parenchyma must be weighed against the oncological outcomes in considering partial nephrectomy (PN) in solitary kidneys. The main objective of this study was to assess the oncologic and functional outcomes after PN in patients with solitary kidneys. Methods A retrospective analysis of the Columbia University Medical Center Urologic Oncology database found 38 patients who underwent PN in the setting of a solitary kidney from 1988–2008. Chronic kidney disease (CKD) was defined as GFR of 2. Kaplan–Meier analysis was used to estimate overall survival, cancer-specific survival, and local recurrence-free survival. Results The study group was followed for a median of 29 months, with a mean age of 63.2 years (range 35–83). Only one patient required postoperative long-term hemodialysis. Two out of 38 patients had a Clavien III postoperative complication. Twenty-one (55.3%) of the patients had preoperative CKD, while 29 (76%) patients had CKD postoperatively. Those who had CKD at the most recent follow-up had significantly larger tumors removed (P < 0.05). Of the 32 patients with renal cell carcinoma (RCC), 6 (18.8%) had a local recurrence at a median 32.6 months. The 5-year overall, disease-specific, and recurrence-free survival rates were 59.6, 77.5, and 45.7%, respectively. Conclusion PN in the setting of a solitary kidney poses difficult challenges for surgical and clinical management. Nephron sparing surgery for the treatment of RCC is feasible with low surgical complication rates, satisfactory disease-specific survival rates, and acceptable preservation of renal function.


    • 1 June 2009
      • Vol. 16  (3) , 4664-9

    Robot-assisted radical cystoprostatectomy in complex surgical patients: single institution report.

    by Daniel J Lee, Michael B Rothberg, James M McKiernan, Mitchell C Benson, Ketan K Badani

    To evaluate the safety and feasibility of robotic-assisted radical cystoprostatectomy (RRCP) in a salvage setting for patients with a history of radiation and chemotherapy treatment, complex pelvic anatomy, and significant comorbidities. Over a 5 month period, six patients who met these criteria underwent RRCP for urothelial carcinoma. Two of the patients had major cardiovascular disease and were previously denied an open procedure subsequently underwent chemotherapy with external beam radiation protocol. One patient had brachytherapy for prior prostate cancer, and three additional patients had neoadjuvant chemotherapy with large diverticula, measuring up to 12 cm in size. Data was collected on patient demographics, comorbidities, intraoperative parameters, and postoperative outcomes. The mean age was 70.4 years (range 53-84 years) with an average BMI of 25.8 (23.33-28.37). All patients were male. All six RRCPs were completed without intraoperative complications or open conversion. The estimated blood loss was 296 cc (150 cc-500 cc). Four patients had pathologic pT3a disease, one patient had pT4a, and one patient had pT1 urethral squamous cell carcinoma. Four of the patients had positive nodes. All six patients had negative surgical margins. The patients were discharged within a mean of 12 days (range 7-28 days). Robot-assisted radical cystoprostatectomy is a minimally invasive option in men with complex surgical anatomy and multiple comorbidities. Short term follow up indicates good clinical and pathologic outcome and physiologic benefit of minimally invasive surgery. However a larger cohort with long term follow up is needed to assess the oncologic efficacy of RRCP.